Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Jun;4(6):818–828. doi: 10.1158/1940-6207.CAPR-10-0376

Table 3.

Adverse events

Adverse Event Grade 1/2 (%) Grade 3/4 (%)
Rash 55 6
Triglycerides 74 13
Diarrhea 31 0
Cholesterol 32 0
Thyroxine (T4) 38 0
T3 elevated 60 0
ALT 27 3
AST 30 3
Alkaline phosphatase 24 0
Total bilirubin 8 3
Leukopenia 14 3
Hypokalemia 5 0
Hyponatremia 11 0
Eosinophilia 0 3
Hemoptysis NA 10
Dyspnea NA 10
Pneumonia (post-obstructive) NA 10 (8)
Pleural effusion NA 8
Confusion NA 10
Abdominal pain NA 3
Acute renal failure NA 3

Abbreviations: ALT, aspartate aminotransferase; AST, alanine aminotransferase; NA, not assessed.